The decline in the mortality rates of cervical cancer and a plausible explanation in Shandong, China

International Journal of Epidemiology

Volumn 29, Issue 3, 2000, Pages 398-404

  Li, Hui Qing ^a   Jin, Shi Quan ^a   Xu, Hai Xiu ^a   Thomas, David B ^b  

^a SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG FIRST MEDICAL UNIVERSITY   (China)

^b Fred Hutchinson Cancer Research Center   (United States)

Author keywords

Age period cohort analysis; Cervical cancer; Correlation study; Cross sectional study; Decline mortality

Indexed keywords

CANCER; HEALTH RISK; MORTALITY; WOMENS HEALTH;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER EPIDEMIOLOGY; CANCER MORTALITY; CANCER RISK; CHINA; CITY; COHORT ANALYSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; RURAL AREA; SEXUAL MATURITY; SYPHILIS; UTERINE CERVIX CANCER;

CHINA; SHANDONG PROVINCE;

EID: 0033949186     PISSN: 03005771     EISSN: None     Source Type: Journal    
DOI: 10.1093/intjepid/29.3.398     Document Type: Article

References (49)

1. Ministry of Health of China. Atlas of Cancer Mortality in the People's Republic of China. Published by China, 1979, pp.47-50.
2. Li LD, Lu FZ, Zhang SW et al. Epidemic distribution of malignant tumor deaths during 1990-1992 in China. J Chin Tumor 1996;18:403-07.
3. World Health Organization. International Classification of Diseases. Ninth Revision. Geneva: WHO, 1976.
4. Frost WH. The age selection of mortality from tuberculosis in successive decades. Am J Hyg 1939;30:91-96.
5. Kupper LL, Janis JM, Karmous A, Greenberg BG. Variance and dissent: statistical age-period-cohort analysis: a review and critique. J Chron Dis 1985;8:811-30.
6. Hygiene Bureau of Shandong: Experience of Preventive Medicine in Shandong Province. Hygiene Bureau of Shandong, 1987, pp.406-07.
7. Waterhouse J, Muir C, Correa P, Powell J. Cancer Incidence in Five Continents. Vol III. IARC Scientific Publication No. 15. Lyon: International Agency for Research on Cancer, 1976.
8. Waterhouse J, Muir CS, Shanmugartnam K, Powell J. Cancer Incidence in Five Continents. Vol V. IARC Scientific Publication No. 42. Lyon: International Agency for Research on Cancer, 1982.
9. Muir CS, Waterhouse J, Mack T, Powell J, Whelan S. Cancer Incidence in Five Continents. Vol VI. IARC Scientific Publication No. 88. Lyon: International Agency for Research on Cancer, 1987.
10. Parkin DM, Muir CS, Whelan SL, Gao YT, Ferlay J, Powell J. Cancer Incidence in Five Continents. Vol VI. IARC Scientific Publication No. 120. Lyon: International Agency for Research on Cancer, 1992.
11. Parkin DM, Muir CS, Whelan SL, Ferlay J, Raymond L, Young J. Cancer Incidence in Five Continents. Vol VII. IARC Scientific Publication No. 143. Lyon: International Agency for Research on Cancer, 1997.
12. Wu LY, Semenya KA, Hardy RE et al. Cancer rate differentials between blacks and whites in three metropolitan areas: a 10-year comparison. J Nat Med Assoc 1998;90:410-16.
13. Sala M, Dosemeci M, Zahm SH. A death certificate-based study of occupation and mortality from reproductive cancers among women in 24 US states. J Occup Environ Med 1998;40:632-39.
14. Igarashi T, Konno R, Sato S et al. A. Characteristics of uterine cancer detected by mass screening. Jap J Cancer Chemo 1998;25:1519-26.
15. Vioque J, Fenollar J. The distribution of cervical cancer mortality in Spain (1981-1986). An ecological study. Med Clin 1995;104:287-92.
16. Lamont DW, Symonds RP. Uptake of cervical screening. Br J Cancer 1993;68:824.
17. Straton JA, Holman CD, Edwards BM. Cervical cancer screening in Western Australia in 1992: progress since 1983. Med J Aust 1993;159: 65-71
18. Aareleid T, Pukkala E, Thomson H et al. Cervical cancer incidence and mortality trends in Finland and Estonia: a screened vs. an unscreened population. Eur J Cancer 1993;29A:745-49.
19. Faggiano F, Partanen T, Kogevinas M et al, Socioeconomic Differences in Cancer Incidence and Mortality. IARC Scientific Publications No. 138. Lyon: International Agency for Research on Cancer, 1997, pp.65-176.
20. Franco EL, Filho NC, Villa LL et al. Correlation patterns of cancer relative frequencies with some socio economic and demographic indicators in Brazil: an ecologic study. Int J Cancer 1988;41:24-29.
21. Coleman MP, Esteve J, Damiecki P, Arslan A, Renard H. World Health Organization International Agency for Research on Cancer. Trends in Cancer Incidence and Mortality. IARC Scientific Publications No. 121. Lyon: International Agency for Research on Cancer, 1993, pp.42-446.
22. Li HQ, Jin SK, Wu F et al. A method of survival analysis for patients with cervical cancer in Cangshan county, Shandong. Chin J Health Stat 1993;10:29.
23. Slattery ML, Overall JC Jr, Abbott TM et al. Sexual activity, contraception, genital infections, and cervical cancer: support for a sexually transmitted disease hypothesis. Am J Epidemiol 1989;130:248-58.
24. Peng HQ, Liu SL, Mann V et al. Human papilloma virus types 16 and 33, herpes simples virus type 2 and other risk factors for cervical cancer in Sichuan province, China. Int J Cancer 1991;7:711-16.
25. Donnan SPB, Wong FWS, Ho SC et al. Reproductive and sexual risk factors and Human papilloma virus infection in cervical cancer among Hong Kong Chinese. Int J Epidemiol 1989;18:32-36.
26. de Sanjose S, Bosch FX, Munoz N et al. Socioeconomic differences in cervical cancer: two case-control studies in Colombia and Spain. Am J Public Health 1996;86:1532-38.
27. Thomas DB, Ray RM, Pardthaisong T et al. Prostitution, condom use, and invasive squamous cell cervical cancer in Thailand. Am J Epidemiol 1996;143:779-86.
28. Sanchez-Vega JT, Torres ME, Tay-Zavala J et al. Frequency of intraepithelial neoplasia of the cervix and risk factors in women in Mexico City. Ginecol Obstet Mex 1997;65:3-7.
29. Biswas LN, Manna B, Maiti PK et al. Sexual risk factors for cervical cancer among rural Indian women: a case-control study. Int J Epidemiol 1997;26:491-95.
30. Munoz N, Bosch FX. Cervical cancer and human papillomavirus: epidemiological evidence and perspective for prevention. Salud Pitblica Mex 1997;39:274-82.
31. de Sanjose S, Bosch FX, Munoz N et al. Social Differences in Sexual Behaviour and Cervical Cancer. Lyon: IARC Scientific Publication No. 138. Lyon: International Agency for Research on Cancer, 1997, pp.309-17.
32. Yoo KY, Kang D, Koo HW et al. Risk factors associated with uterine cervical cancer in Korea: a case-control study with special reference to sexual behavior. J Epidemiol 1997;7:117-23.
33. Becker TM, Lee F, Daling JR et al. Seroprevalence of and risk factors for antibodies to herpes simplex viruses, hepatitis B, and hepatitis C among southwestern Hispanic and non-Hispanic white women. Sex Transm Dis 1996;23:138-44.
34. Daling JR, Madeleine MM, McKnight B et al. The relationship of human Papillomavirus-related cervical tumors to cigarette smoking, oral contraceptive use, and prior herpes simplex virus type 2 infection. Cancer Epidemiol Biomark Prev 1996;5:541-48.
35. Gomes C, Dias M, Falcao F et al. Serologic profile of some sexually transmitted diseases in women with squamous intraepithelial lesions. Eur J Gynaecol Oncol 1998;19:135-37.
36. Chichareon S, Herrero R, Munoz N et al. Risk factors for cervical cancer in Thailand: a case-control study. J Natl Cancer Inst 1998;90:50-57.
37. Ngelangel C, Munoz N, Bosch FX et al. Causes of cervical cancer in the Philippines: a case-control study. J Natl Cancer Inst 1998;90:43-49.
38. Svare EI, Kjaer SK, Worm AM et al. Risk factors for HPV infection in women from sexually transmitted disease clinics: comparison between two areas with different cervical cancer incidence. Int J Cancer 1998;75:1-8.
39. Svare EI, Kjaer SK, Smits HL et al. Risk factors for HPV detection in archival Pap smears. A population-based study from Greenland and Denmark. Eur J Cancer 1998;34:1230-34.
40. Han CP, Tsao YP, Sun CA et al. Human Papillomavirus, cytomegalovirus and herpes simplex virus infections for cervical cancer in Taiwan. Cancer Lett 1997;120:217-21.
41. Reyes-Maldonado E, Diaz-Fuente LA, Gonzalez-Bonilla CV et al. Detection of Chlamydia trachomatis by immunofluorescence, Papanicolaou and immunoperoxidase in women with leucorrhea Rev Latinoam Microbiol 1996;38:65-73.
42. Castellsague X, Ghaffari A, Daniel RW et al. Prevalence of penile human Papillomavirus DNA in husbands of women with and without cervical neoplasia: a study in Spain and Colombia. J Infect Dis 1997; 176:353-61.
43. Birley HD. Human Papillomaviruses, cervical cancer and the developing world. Ann Trop Med Parasitol 1995;89:453-63.
44. Matsuura Y, Kawagoe T, Toki N et al. Low grade cervical intraepithelial neoplasia associated with human Papillomavirus infection. Long-term follow-up. Acta Cytol 1998;42:625-30.
45. La Ruche G, You B, Mensah-Ado I et al. Papillomavirus and human immunodeficiency virus infections: relation with cervical dysplasianeoplasia in African women. Int J Cancer 1998;76:480-86.
46. Ho GY, Burk RD, Klein S et al. Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia J Natl Cancer Inst 1995;87:136 5-71.
47. Schiffman MH. New epidemiology of human papillomavirus infection and cervical neoplasia. J Natl Cancer Inst 1995;87:1345-47.
48. Yang G, Xue HS, He YJ, Ma JM. The results of the behavior risk factors and community environment surveillance related STD/HIV in 8 cities of China. Int Conf AIDS 1998;12:234.
49. Liu H, Xie J, Yu W et al. A study of sexual behavior among rural residents of China. J Acquir Immune Defic Syndr Hum Retrovir 1998; 19:80-88.